The DOI matches its Crossref record; 225 of the 225 references it cites were found in a registry or an index.
Nanotechnology for Cancer Therapy Based on Chemotherapy
Open accessAbstract
Chemotherapy has been widely applied in clinics. However, the therapeutic potential of chemotherapy against cancer is seriously dissatisfactory due to the nonspecific drug distribution, multidrug resistance (MDR) and the heterogeneity of cancer. Therefore, combinational therapy based on chemotherapy mediated by nanotechnology, has been the trend in clinical research at present, which can result in a remarkably increased therapeutic efficiency with few side effects to normal tissues. Moreover, to achieve the accurate pre-diagnosis and real-time monitoring for tumor, the research of nano-theranostics, which integrates diagnosis with treatment process, is a promising field in cancer treatment. In this review, the recent studies on combinational therapy based on chemotherapy will be systematically discussed. Furthermore, as a current trend in cancer treatment, advance in theranostic nanoparticles based on chemotherapy will be exemplified briefly. Finally, the present challenges and improvement tips will be presented in combination therapy and nano-theranostics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–225 of 225
Berstein, L. M. (2010) · Future Oncology · doi:10.2217/fon.10.87 · Cited by 49
Yan, S., Lü, M., Ding, X., Chen, F., He, X., Xu, C., Zhou, H., Wang, Q., Hao, L., & Zou, J. (2016) · Scientific Reports · doi:10.1038/srep31833 · Cited by 45
LabeledIn: Cataloging labeled indications for human drugs
Khare, R., Li, J., & Lu, Z. (2014) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2014.08.004 · Cited by 44
Mabuchi, S., Isohashi, F., Yokoi, T., Takemura, M., Yoshino, K., Shiki, Y., Ito, K., Enomoto, T., Ogawa, K., & Kimura, T. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.02.011 · Cited by 43
Zhang, C., Zhao, X., Guo, S., Lin, T., & Guo, H. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s130539 · Cited by 43
Triple Block Nanocarrier Platform for Synergistic Cancer Therapy of Antagonistic Drugs
Surnar, B., & Jayakannan, M. (2016) · Biomacromolecules · doi:10.1021/acs.biomac.6b01608 · Cited by 42
Wang, H., Wang, H., Liang, J., Jiang, Y., Guo, Q., Peng, H., Xu, Q., & Huang, Y. (2014) · Molecular Pharmaceutics · doi:10.1021/mp5001058 · Cited by 41
Shi, J., Su, Y.-C., Liu, W., Chang, J., & Zhang, Z. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s143776 · Cited by 39
Wang, A. Z., Cummings, N. D., Sethi, M., Wang, E. C., Sukumar, R., Moore, D., & Werner, M. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.e13546 · Cited by 37
Dullin, C., Monego, S. D., Larsson, E., Mohammadi, S., Krenkel, M., Garrovo, C., Biffi, S., Lorenzon, A., Markus, M. A., Napp, J., et al. (2014) · Journal of Synchrotron Radiation · doi:10.1107/s1600577514021730 · Cited by 34
Chen, Z., Zhu, P., Zhang, Y., Liu, Y., He, Y., Zhang, L., & Gao, Y. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00352 · Cited by 34
Light and pH dual‐sensitive biodegradable polymeric nanoparticles for controlled release of cargos
Xia, Y., Zeng, Y., Hu, D. Y., Shen, H., Deng, J., Lu, Y., Xia, X., & Xu, W. (2017) · Journal of Polymer Science Part A Polymer Chemistry · doi:10.1002/pola.28528 · Cited by 33
Mao, J., Tang, S., Hong, D., Zhao, F., Niu, M., Han, X., Qi, J., Bao, H., Yutian, J., Fu, C., et al. (2017) · Nanoscale · doi:10.1039/c6nr09862b · Cited by 33
Modalities for Imaging of Prostate Cancer
Hou, A. H., Swanson, D. A., & Barqawi, A. B. (2009) · Advances in Urology · doi:10.1155/2009/818065 · Cited by 32
Luo, Y., Wu, H., Feng, C., Xiao, K., Xixiao, Y., Liu, Q., Lin, T., Zhang, H., Walton, J. H., Ajena, Y., et al. (2017) · Theranostics · doi:10.7150/thno.20190 · Cited by 32
Improving chemoradiotherapy with nanoparticle therapeutics.
Eblan, M. J., & Wang, A. Z. (2013) · PubMed · doi:10.3978/j.issn.2218-676x.2013.08.04 · Cited by 31
Li, L., Cui, D., Ye, L., Li, Y., Zhu, L., Yang, L., Bai, B., Nie, Z., Gao, J., & Cao, Y. (2017) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000541 · Cited by 29
Hu, X., Li, J., Lin, W., Huang, Y., Jing, X., & Xie, Z. (2014) · RSC Advances · doi:10.1039/c4ra06270a · Cited by 28
Zhu, X., Huang, H., Zhang, Y., et al. (2016) · Journal of Biomaterials Applications · doi:10.1177/0885328216676159 · Cited by 28
An enhanced chemotherapeutic effect facilitated by sonication of MSN
Ding, Y., Song, Z., Liu, Q., Wei, S., Zhou, L., Zhou, J., & Shen, J. (2017) · Dalton Transactions · doi:10.1039/c7dt02600e · Cited by 27
Nanocarrier-based immunotherapy in cancer management and research
Bhaskar, S., & Singh, M. S. (2014) · ImmunoTargets and Therapy · doi:10.2147/itt.s62471 · Cited by 24
Structure Dependence of Lysosomal Transit of Chitosan-Based Polyplexes for Gene Delivery
Thibault, M., Lavertu, M., Astolfi, M., & Buschmann, M. D. (2016) · Molecular Biotechnology · doi:10.1007/s12033-016-9964-8 · Cited by 16
Krishnamurthy, S., Ng, V. W. L., Gao, S., Tan, M., Hedrick, J. L., & Yang, Y. Y. (2015) · Nanomedicine · doi:10.2217/nnm.15.109 · Cited by 12
Moradpoor, R., Aledavood, S. A., Rajabi, O., Chamani, J., & Sazgarnia, A. (2017) · Iranian Journal of Cancer Prevention · doi:10.17795/ijcp-5925 · Cited by 9
Luo, Z., Gong, P., Sheng, Z., Gao, G., PengFei, Z. H. A. O., Zheng, M., Cai, L., & Zhang, P. (2014) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/n972014-00280 · Cited by 8
Cited by
Clinical development and potential of photothermal and photodynamic therapies for cancer
Li, X., Lovell, J. F., Yoon, J., & Chen, X. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0410-2 · Cited by 3,456
Nanomaterials for cancer therapy: current progress and perspectives
Cheng, Z., Li, M., Dey, R., & Chen, Y. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01096-0 · Cited by 1,168
Chehelgerdi, M., Chehelgerdi, M., Allela, O. Q. B., Pecho, R. D. C., Jayasankar, N., Rao, D. P., Thamaraikani, T., Vasanthan, M., Viktor, P., Lakshmaiya, N., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01865-0 · Cited by 1,062
Nanoparticle Surface Functionalization: How to Improve Biocompatibility and Cellular Internalization
Sanità, G., Carrese, B., & Lamberti, A. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.587012 · Cited by 765
Gunaydin, G., Gedik, M. E., & Ayan, S. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.686303 · Cited by 402
Metadata
- Authors
- Zhao, C.-Y., Cheng, R., Yang, Z., & Tian, Z.-M.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2018-04-04
- Volume
- 23
- Issue
- 4
- Pages
- 826
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2796117568
- Cited by
- 330
- References
- 225
- FWCI
- 9.22
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.